INCYTE CORPORATION Increase (Decrease) in Deferred Revenue
INCYTE CORPORATION (INCY) reported Increase (Decrease) in Deferred Revenue of -$2.33 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-02-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2015-02-17
- INCYTE CORPORATION increase (decrease) in deferred revenue for the quarter ending 2012-12-31 was $0.00, a 100.00% decline year-over-year.
- INCYTE CORPORATION increase (decrease) in deferred revenue for the quarter ending 2012-09-30 was -$8.99M.
- INCYTE CORPORATION increase (decrease) in deferred revenue for the quarter ending 2012-06-30 was $2.99M.
- INCYTE CORPORATION increase (decrease) in deferred revenue for the quarter ending 2012-03-31 was $3.67M.
- INCYTE CORPORATION increase (decrease) in deferred revenue for fiscal 2012 was -$2.33M, a 200.00% decline from fiscal 2011.
- INCYTE CORPORATION increase (decrease) in deferred revenue for fiscal 2011 was $2.33M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$8.99M derived: sum of 2 quarters · filed 2015-02-17 | -$6.00M derived: sum of 3 quarters · filed 2015-02-17 | -$2.33M 10-K · filed 2015-02-17 |
| 2012-09-30 | -$8.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | -$6.00M derived: sum of 2 quarters · filed 2013-10-31 | -$2.33M 10-Q · filed 2013-10-31 | $50.21M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $6.66M 10-Q · filed 2013-08-01 | $59.20M derived: sum of 3 quarters · filed 2014-02-21 | $42.46M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-03-31 | $3.67M 10-Q · filed 2013-05-02 | $56.22M derived: sum of 2 quarters · filed 2014-02-21 | $39.48M derived: sum of 3 quarters · filed 2014-02-21 | $22.74M derived: sum of 4 quarters · filed 2014-02-21 |
| 2011-12-31 | $52.54M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $35.80M derived: sum of 2 quarters · filed 2014-02-21 | $19.06M derived: sum of 3 quarters · filed 2014-02-21 | $2.33M 10-K · filed 2014-02-21 |
| 2011-09-30 | -$16.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$33.48M derived: sum of 2 quarters · filed 2011-10-27 | -$50.21M 10-Q · filed 2011-10-27 | |
| 2011-06-30 | -$16.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$33.47M 10-Q · filed 2011-07-28 | ||
| 2011-03-31 | -$16.73M 10-Q · filed 2011-05-03 | |||
| 2010-09-30 | -$16.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$33.51M derived: sum of 2 quarters · filed 2011-10-27 | -$50.26M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | -$16.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$33.50M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$16.75M 10-Q · filed 2011-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |